Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (651-660 of 1,142) with videos related to

Pageof 115
Sort By:
International Clinical Psychopharmacology|May 4, 2010
Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesiaRenan P Souza, Gary Remington, Herbert Y Meltzer, et al.
Gastro Hep Advances|April 24, 2026
Optimizing Colonoscopy Capacity to Maximize Colorectal Cancer OutcomesA Mark Fendrick, Jacob E Kurlander, Vahab Vahdat, et al.
Biological Psychiatry|December 4, 1998
Serotonergic basis of antipsychotic drug effects in schizophreniaJ A Lieberman, R B Mailman, G Duncan, et al.
American Journal of Clinical Pathology|May 6, 2025
The clinical pathology laboratory in 360° virtual realityHamilton C Tsang, Ryan J Morse, Jing Zhang, et al.
Fertility and Sterility|October 8, 2010
Gene expression analysis of a new source of human oocytes and embryos for research and human embryonic stem cell derivationSharon F Sneddon, Paul A DeSousa, Ruth E Arnesen, et al.
The American Journal of Psychiatry|December 8, 2006
Effectiveness of switching antipsychotic medicationsSusan M Essock, Nancy H Covell, Sonia M Davis, et al.
Gastroenterology|March 1, 1987
Metabolic bone disease in asymptomatic men after partial gastrectomy with Billroth II anastomosisK B Klein, E S Orwoll, D A Lieberman, et al.
Schizophrenia Bulletin|July 29, 2004
Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effectsRael D Strous, Jose M J Alvir, Delbert Robinson, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Cellular mechanisms which distinguish between hormone- and antihormone-activated estrogen receptorD P McDonnell, S L Dana, P A Hoener, et al.
Neurology|October 22, 1998
A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study GroupA Lieberman, C W Olanow, K Sethi, et al.
Pageof 115

Showing results (651-660 of 1,142) with videos related to

Sort By:
Pageof 115
International Clinical Psychopharmacology|May 4, 2010
Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesiaRenan P Souza, Gary Remington, Herbert Y Meltzer, et al.
Gastro Hep Advances|April 24, 2026
Optimizing Colonoscopy Capacity to Maximize Colorectal Cancer OutcomesA Mark Fendrick, Jacob E Kurlander, Vahab Vahdat, et al.
Biological Psychiatry|December 4, 1998
Serotonergic basis of antipsychotic drug effects in schizophreniaJ A Lieberman, R B Mailman, G Duncan, et al.
American Journal of Clinical Pathology|May 6, 2025
The clinical pathology laboratory in 360° virtual realityHamilton C Tsang, Ryan J Morse, Jing Zhang, et al.
Fertility and Sterility|October 8, 2010
Gene expression analysis of a new source of human oocytes and embryos for research and human embryonic stem cell derivationSharon F Sneddon, Paul A DeSousa, Ruth E Arnesen, et al.
The American Journal of Psychiatry|December 8, 2006
Effectiveness of switching antipsychotic medicationsSusan M Essock, Nancy H Covell, Sonia M Davis, et al.
Gastroenterology|March 1, 1987
Metabolic bone disease in asymptomatic men after partial gastrectomy with Billroth II anastomosisK B Klein, E S Orwoll, D A Lieberman, et al.
Schizophrenia Bulletin|July 29, 2004
Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effectsRael D Strous, Jose M J Alvir, Delbert Robinson, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Cellular mechanisms which distinguish between hormone- and antihormone-activated estrogen receptorD P McDonnell, S L Dana, P A Hoener, et al.
Neurology|October 22, 1998
A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study GroupA Lieberman, C W Olanow, K Sethi, et al.
Pageof 115